# Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes

> **NCT02814747** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 530 (estimated)

## Conditions studied

- Rare Diseases

## Interventions

- **OTHER:** quantitive study: 500 patients likely to be candidates for HTS
- **OTHER:** qualitative study: 30 patients who have benefited from HTS

## Key facts

- **NCT ID:** NCT02814747
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2016-02
- **Final completion:** —
- **Target enrollment:** 530 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02814747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02814747, "Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02814747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*